Pancreatic Cancer Research

ResearcherLeiden University Medical CenterNo recent work listed

Thomas P. Brouwer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9947-6727; OpenAlex author ID A5026322751. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers

Papers 4

  1. The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancer. Co-author DOI 10.1097/cad.0000000000001283↗
  2. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry. Co-author DOI 10.1136/jitc-2022-004638↗
  3. A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer. Co-author DOI 10.3390/cancers14163862↗
  4. Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel. Co-author DOI 10.1007/s13402-021-00587-z↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Noel F.C.C. de Miranda · 4 shared papers, 2021–2022 · strength 0.67
  2. Alexander L. Vahrmeijer · 4 shared papers, 2021–2022 · strength 0.67
  3. Bert A. Bonsing · 3 shared papers, 2022 · strength 0.45
  4. Hans Morreau · 2 shared papers, 2022 · strength 0.28
  5. Frederike Dijk · 1 shared paper, 2022 · strength 0.15
  6. Ricki T. Krog · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.